4886 ASKA Pharmaceutical Holdings

Watchlist

1941
+19+0.99%

20min DelayTrading Jan 20 12:56 JST

59.32BMarket Cap7.28P/E (Static)

ASKA Pharmaceutical Holdings Key Stats

According to the latest financial report of ASKA Pharmaceutical Holdings, the latest earnings per share (TTM) for the company is 44.95. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: JPY

Quarterly

FCF

Interested in knowing about ASKA Pharmaceutical Holdings's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.

Currency: JPY

Quarterly

Current Ratio

If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of ASKA Pharmaceutical Holdings shows that the company's current ratio is 2.82, indicating healthy liquidity.

Currency: JPY

Quarterly

Quick Ratio

Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of ASKA Pharmaceutical Holdings, the quick ratio is 1.57, indicating that the company can meet its short-term debt obligations.

Currency: JPY

Quarterly

ROE

Want to learn more about the financial health of ASKA Pharmaceutical Holdings? The latest ROE figure is 1.78%, indicating that the company has stable profitability.

Currency: JPY

Quarterly

ROA

Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of ASKA Pharmaceutical Holdings, the total asset return on investment (ROA) is 1.17%.

Currency: JPY

Quarterly

Gross Margin

Gross margin can provide insight into a company's pricing strategy and cost structure. Check ASKA Pharmaceutical Holdings's latest financial report to see how their gross margin is doing - currently at 49.97%.

Currency: JPY

Quarterly

Net Margin

For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of ASKA Pharmaceutical Holdings, the net profit margin is 7.78%, which is a good sign for its profitability.

Currency: JPY

Quarterly

Symbol Price % Chg